EyeControl specializes in communication solutions that address unmet healthcare needs.

The company implements AI technologies that connect people and bridge information barriers, facilitating better medical care and decision-making.EyeControl's eye-tracking wearable and smart platforms empower comprehensive, round-the-clock, bi-directional connectivity between patients with communication difficulties, their families, and medical teams.Using adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time communication and actionable clinical data for patients with various levels of cognition.EyeControl is a privately held, rapidly growing start-up.

Recognized for its medical innovation, the company is supported by the European Innovation Council, Israel Innovation Authority, investors, and advisors representing various sectors.The EyeControl device is FDA listed, CE marked, ISO certified, AMAR and MAKAT registered, and HIPAA/GDPR compliant; it is federally reimbursed in Israel, the United Kingdom, and United States.

Clinical trials validating its efficacy in detecting and mitigating delirium are underway in Israel and the United States.